Impact of germline TP53 mutations and polymorphisms in women with premenopausal breast cancer

被引：0
|
作者：
Samuel, Nardin
Novokmet, Ana
Hudson, Thomas J.
Malkin, David
机构：
来源：
CANCER RESEARCH | 2014年 / 74卷 / 23期
关键词：
D O I：
10.1158/1538-7445.CANSUSC14-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TP53 germline mutation testing in early onset breast cancer
    Conte, B.
    Varesco, L.
    Iacono, G.
    Poggio, F.
    Blondeaux, E.
    Levaggi, A.
    D'Alonzo, A.
    Bighin, C.
    Giraudi, S.
    Vaglica, M.
    Pronzato, P.
    Del Mastro, L.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [42] Germline TP53 pathogenic variants and breast cancer: A narrative review
    Blondeaux, Eva
    Arecco, Luca
    Punie, Kevin
    Graffeo, Rossella
    Toss, Angela
    De Angelis, Carmine
    Trevisan, Lucia
    Buzzatti, Giulia
    Linn, Sabine C.
    Dubsky, Peter
    Cruellas, Mara
    Partridge, Ann H.
    Balman, Judith
    Paluch-Shimon, Shani
    Lambertini, Matteo
    [J]. CANCER TREATMENT REVIEWS, 2023, 114
  • [43] Early onset HER2-positive breast cancer is associated with germline TP53 mutations
    Melhem-Bertrandt, Amal
    Bojadzieva, Jasmina
    Ready, Kaylene J.
    Obeid, Elias
    Liu, Diane D.
    Gutierrez-Barrera, Angelica M.
    Litton, Jennifer K.
    Olopade, Olufunmilayo I.
    Hortobagyi, Gabriel N.
    Strong, Louise C.
    Arun, Banu K.
    [J]. CANCER, 2012, 118 (04) : 908 - 913
  • [44] Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
    Kwong, Ava
    Shin, Vivian Yvonne
    Ho, Cecilia Y. S.
    Au, Chun Hang
    Slavin, Thomas P.
    Weitzel, Jeffrey N.
    Chan, Tsun-Leung
    Ma, Edmond S. K.
    [J]. BMC CANCER, 2020, 20 (01)
  • [45] Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
    Ava Kwong
    Vivian Yvonne Shin
    Cecilia Y. S. Ho
    Chun Hang Au
    Thomas P. Slavin
    Jeffrey N. Weitzel
    Tsun-Leung Chan
    Edmond S. K. Ma
    [J]. BMC Cancer, 20
  • [46] TP53 germline mutations in young females with early onset breast cancer in a Mexican population.
    Gallardo, Lenny Nadia
    Tusie-Luna, Teresa
    Tusie-Luna, Maria Isabel
    Diaz-Chavez, Jose
    Medina, Enrique Macario Herrera
    Chavez-Mac Gregor, Mariana
    Rocha, Enrique Bargallo
    Kato, Yayoi Xcchitl Segura
    Villarreal, Cynthia
    Montalvo, Luis Alonso Herrera
    Cantu-de Leon, David Franciso
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] TP53 and breast cancer
    Borresen-Dale, AL
    [J]. HUMAN MUTATION, 2003, 21 (03) : 292 - 300
  • [48] Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
    Fang, Shenying
    Krahe, Ralf
    Lozano, Guillermina
    Han, Younghun
    Chen, Wei
    Post, Sean M.
    Zhang, Baili
    Wilson, Charmaine D.
    Bachinski, Linda L.
    Strong, Louise C.
    Amos, Christopher I.
    [J]. PLOS ONE, 2010, 5 (05):
  • [49] Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk
    Samuel, Nardin
    Id Said, Badr
    Guha, Tanya
    Novokmet, Ana
    Li, Weili
    Silwal-Pandit, Laxmi
    Borrsen-Dale, Anne-Lise
    Langerod, Anita
    Hudson, Thomas J.
    Malkin, David
    [J]. HUMAN MUTATION, 2017, 38 (03) : 265 - 268
  • [50] TP53 mutations in familial breast cancer: Functional aspects
    Gasco, M
    Yulug, IG
    Crook, T
    [J]. HUMAN MUTATION, 2003, 21 (03) : 301 - 306
12345